Abstract
The attack ratio in a subpopulation is defined as the total number of infections over the total number of individuals in this subpopulation. Using a methodology based on modified age-stratified transmission dynamics model, we estimated the attack ratio of COVID-19 among children (individuals 0-11 years) in Ontario, Canada when a large proportion of individuals eligible for vaccination (age 12 and above) are vaccinated to achieve herd immunity among this subpopulation, or the effective herd immunity with additional physical distancing measures (hence effective herd immunity). We describe the relationship between this attack ratio among children, the time to remove infected individuals from the transmission chain and the children-to-children daily contact rate, while considering the increased transmissibility of virus variants (using the Delta variant as an example). We further illustrate the generality and applicability of the methodology established by performing an analysis of the attack ratio of COVID-19 among children in the Canadian population. The clinical attack ratio, the number of symptomatic infections over the total population can be informed from the attack ratio, and both can be reduced substantially via a combination of higher vaccine coverage in the vaccine eligible population, reduced social mixing among children, and rapid testing and isolation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project has been partially supported by the Canadian Institute of Health Research (CIHR) 2019 Novel Coronavirus (COVID-19) rapid research program, and the Natural Science and Engineering Research Council of Canada (NSERC) and Public Health Agency of Canada (PHAC) Emerging Infectious Disease Modelling program for MfPH, Mathematics for Public Health. FS is supported by the UKRI through the JUNIPER modelling consortium [grant number MR/V038613/1].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All data used in the this study is publicly available and were openly available before the initiation of the study and can be accessed without application, or screening, or registration for access.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data used in the this study is publicly available and were openly available before the initiation of the study and can be accessed without application, or screening, or registration for access. All external data sources have been cited within and their source reported in the reference list. For verification purposes, the direct links for the dataset/web page which includes the vaccination coverage in Ontario, Canada and Canada used in the study are available at the links provided in the Data Availability Links. The two links provided are for the vaccination coverage in Canada dataset (Reference 40) and vaccination coverage in Ontario, Canada (Reference 30), provided in the form of an archive link to the web page live on August 27, 2021. Regarding the simulation code, inquiries can be directed to the corresponding author.
https://health-infobase.canada.ca/src/data/covidLive/vaccination-coverage-map.csv
https://web.archive.org/web/20210827212748/ https://covid-19.ontario.ca/data
